Congratulations to Deborah Heart and Lung Centerโs Richard Kovach, MD (shown left) and the interventional cardiology team on performing their first renal denervation procedure.
Results of the independent, investigator-initiated DanGer Shock RCT, presented as an #ACC24 Late-Breaker and published in @NEJM, confirm routine use of Impella CP reduces 180-day mortality by 12.7%, compared to the control arm without Impella.
In the end, We all suffer from these biases to different degrees. Recognizing our own biases makes us better operators.
Taking time not to rush to a conclusion can save a case from a bad unnecessary "commission" or "omission"
#cardiotwitter
8/x
Q: What is the effect of amyloidosis on outcomes of #TAVR?
A: There was no difference in in-hospital mortality or 30-day readmission rate after TAVR in patients w/ severe aortic stenosis & amyloidosis, compared to patients w/ lone AS.
More: https://t.co/2yV1PFRLfC #JACCAdvances
Canโt tell you how many times this device has saved me in my #ACCEarlyCareer
In training I was all about large bore MCS but it came with a lot of access site issues etc.
IABP has been a great tool especially as a bridge while you stabilize/escalate med therapy.
#Cardiotwitter #IABP #CardiogenicShock #MCS #DetroitShockCity
Rota-shit happens #scarymovie
(how to prevent, how to solve)
@Dchipayog@HennesseyBreda
Transvascular Balloon Occlusion: A Novel Bailout Strategy in Large Lef... https://t.co/oG2xrJqLgQ